Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Recrudescence of Old Stroke Deficits Among Transient Neurological Attacks.

Jun-O'connell AH, Henninger N, Moonis M, Silver B, Ionete C, Goddeau RP.

Neurohospitalist. 2019 Oct;9(4):183-189. doi: 10.1177/1941874419829288. Epub 2019 Feb 21.

PMID:
31534606
2.
3.

Impact of Leukoaraiosis Severity on the Association of Time to Successful Reperfusion with 90-Day Functional Outcome After Large Vessel Occlusion Stroke.

Mikati AG, Mandelbaum M, Sapnar S, Puri AS, Silver B, Goddeau RP Jr, Haussen DC, Moonis M, Jun-O'Connell AH, Henninger N.

Transl Stroke Res. 2019 Apr 12. doi: 10.1007/s12975-019-00703-0. [Epub ahead of print]

PMID:
30980282
4.

Impact assessment of high soil CO2 on plant growth and soil environment: a greenhouse study.

He W, Yoo G, Moonis M, Kim Y, Chen X.

PeerJ. 2019 Jan 25;7:e6311. doi: 10.7717/peerj.6311. eCollection 2019.

5.

Clinical and Radiological Characteristics of Vitamin K Versus Non-Vitamin K Antagonist Oral Anticoagulation-Related Intracerebral Hemorrhage.

Miller MM, Lowe J, Khan M, Azeem MU, Muehlschlegel S, Jun-O'Connell AH, Goddeau RP Jr, Moonis M, Gritters D, Silver B, Henninger N.

Neurocrit Care. 2019 Aug;31(1):56-65. doi: 10.1007/s12028-019-00671-1.

PMID:
30690686
6.

Pre-existing White Matter Hyperintensity Lesion Burden and Diagnostic Certainty of Transient Ischemic Attack.

Nagy M, Azeem MU, Soliman Y, Nawab SA, Jun-O'Connell AH, Goddeau RP Jr, Moonis M, Silver B, Henninger N.

J Stroke Cerebrovasc Dis. 2019 Apr;28(4):944-953. doi: 10.1016/j.jstrokecerebrovasdis.2018.12.022. Epub 2019 Jan 7.

PMID:
30630754
7.

Editorial: Carotid Revasculatization vs Best Medical Management in Symptomatic Carotid Artery Disease.

Moonis M.

Ann Indian Acad Neurol. 2018 Jul-Sep;21(3):171-172. doi: 10.4103/aian.AIAN_156_18. No abstract available.

8.

Depression Effects on Hospital Cost of Heart Failure Patients in California: An Analysis by Ethnicity and Gender.

Husaini BA, Taira D, Norris K, Adhish SV, Moonis M, Levine R.

Indian J Community Med. 2018 Jan-Mar;43(1):49-52. doi: 10.4103/ijcm.IJCM_151_17.

9.

Leukoaraiosis Attenuates Diagnostic Accuracy of Large-Vessel Occlusion Scales.

Mayasi Y, Goddeau RP Jr, Moonis M, Silver B, Jun-O'Connell AH, Puri AS, Henninger N.

AJNR Am J Neuroradiol. 2018 Feb;39(2):317-322. doi: 10.3174/ajnr.A5473. Epub 2017 Nov 23.

10.

Smoking, depression, and hospital costs of respiratory cancers: Examining race and sex variation.

Husaini B, Levine R, Lammers P, Hull P, Novotny M, Moonis M.

Fam Med Community Health. 2017;5(1):29-42. doi: 10.15212/FMCH.2017.0109. Epub 2017 May 1.

11.

Atrial fibrillation is associated with anterior predominant white matter lesions in patients presenting with embolic stroke.

Mayasi Y, Helenius J, McManus DD, Goddeau RP Jr, Jun-O'Connell AH, Moonis M, Henninger N.

J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):6-13. doi: 10.1136/jnnp-2016-315457. Epub 2017 May 27.

12.

Emergency Department Length of Stay and Outcome after Ischemic Stroke.

Minaeian A, Patel A, Essa B, Goddeau RP Jr, Moonis M, Henninger N.

J Stroke Cerebrovasc Dis. 2017 Oct;26(10):2167-2173. doi: 10.1016/j.jstrokecerebrovasdis.2017.04.040. Epub 2017 May 24.

13.

Heart Failure Hospitalization by Race/Ethnicity, Gender and Age in California: Implications for Prevention.

Husaini BA, Levine RS, Norris KC, Cain V, Bazargan M, Moonis M.

Ethn Dis. 2016 Jul 21;26(3):345-54. doi: 10.18865/ed.26.3.345.

14.

Time to Presentation Is Associated with Clinical Outcome in Hemispheric Stroke Patients Deemed Ineligible for Recanalization Therapy.

Mayasi Y, Helenius J, Goddeau RP Jr, Moonis M, Henninger N.

J Stroke Cerebrovasc Dis. 2016 Oct;25(10):2373-9. doi: 10.1016/j.jstrokecerebrovasdis.2016.05.036. Epub 2016 Jun 14.

15.

Impact of Leukoaraiosis Burden on Hemispheric Lateralization of the National Institutes of Health Stroke Scale Deficit in Acute Ischemic Stroke.

Helenius J, Goddeau RP Jr, Moonis M, Henninger N.

Stroke. 2016 Jan;47(1):24-30. doi: 10.1161/STROKEAHA.115.011771. Epub 2015 Nov 10. Erratum in: Stroke. 2016 Jan;47(1):e22.

PMID:
26556825
16.

Dipping to clear amyloid: Cerebrovascular reactivity and neurodegeneration--cause or effect?

Seshadri S, Moonis M.

Neurology. 2015 Dec 1;85(22):1918-9. doi: 10.1212/WNL.0000000000002177. Epub 2015 Nov 4. No abstract available.

PMID:
26537050
17.

Association of Statins with Sensory and Autonomic Ganglionopathy.

Novak P, Pimentel DA, Sundar B, Moonis M, Qin L, Novak V.

Front Aging Neurosci. 2015 Oct 7;7:191. doi: 10.3389/fnagi.2015.00191. eCollection 2015.

18.

Risk Factors and Hospitalization Costs of Dementia Patients: Examining Race and Gender Variations.

Husaini B, Gudlavalleti AS, Cain V, Levine R, Moonis M.

Indian J Community Med. 2015 Oct-Dec;40(4):258-63. doi: 10.4103/0970-0218.164396.

19.

Bilateral Intracranial Vertebral Artery Stenosis Presenting as Recurrent Prolonged Presyncopal Episodes.

Sundar B, Moonis M, Wakhloo A, Puri A.

Case Rep Neurol Med. 2015;2015:251536. doi: 10.1155/2015/251536. Epub 2015 Sep 1.

20.

Pre and Post-stroke Use of Statins Improves Stroke Outcome.

Moonis M, Kumar R, Henninger N, Kane K, Fisher M.

Indian J Community Med. 2014 Oct;39(4):214-7. doi: 10.4103/0970-0218.143021.

21.

Telestroke a viable option to improve stroke care in India.

Srivastava PV, Sudhan P, Khurana D, Bhatia R, Kaul S, Sylaja PN, Moonis M, Pandian JD.

Int J Stroke. 2014 Oct;9 Suppl A100:133-4. doi: 10.1111/ijs.12326. Epub 2014 Jul 18.

PMID:
25042038
22.

Predictors of Outcome following Stroke due to Isolated M2 Occlusions.

Khan M, Goddeau RP Jr, Zhang J, Moonis M, Henninger N.

Cerebrovasc Dis Extra. 2014 Mar 7;4(1):52-60. doi: 10.1159/000360075. eCollection 2014 Jan.

23.

Advances and potential new treatments in stroke management.

Moonis M, Srivastava P, Selim M, Fisher M.

Stroke Res Treat. 2014;2014:120384. doi: 10.1155/2014/120384. Epub 2014 Feb 17. No abstract available.

24.

Leukoaraiosis predicts cortical infarct volume after distal middle cerebral artery occlusion.

Henninger N, Khan MA, Zhang J, Moonis M, Goddeau RP Jr.

Stroke. 2014 Mar;45(3):689-95. doi: 10.1161/STROKEAHA.113.002855. Epub 2014 Feb 12.

PMID:
24523039
25.

Author response.

Mehndiratta MM, Singhal A, Chaturvedi S, Sivakumar MR, Moonis M.

Neurology. 2014 Jan 7;82(1):96. No abstract available.

PMID:
24520571
26.

Intracranial hypotension with multiple complications: an unusual case report.

Ade S, Moonis M.

Case Rep Neurol Med. 2013;2013:913465. doi: 10.1155/2013/913465. Epub 2013 Nov 13.

27.

Meeting the challenges of stroke in India.

Mehndiratta MM, Singhal AB, Chaturvedi S, Sivakumar MR, Moonis M.

Neurology. 2013 Jun 11;80(24):2246-7. doi: 10.1212/WNL.0b013e318296e7c3. Review.

28.

Depression increases stroke hospitalization cost: an analysis of 17,010 stroke patients in 2008 by race and gender.

Husaini B, Levine R, Sharp L, Cain V, Novotny M, Hull P, Orum G, Samad Z, Sampson U, Moonis M.

Stroke Res Treat. 2013;2013:846732. doi: 10.1155/2013/846732. Epub 2013 Mar 10.

29.

Leukoaraiosis and sex predict the hyperacute ischemic core volume.

Henninger N, Lin E, Haussen DC, Lehman LL, Takhtani D, Selim M, Moonis M.

Stroke. 2013 Jan;44(1):61-7. doi: 10.1161/STROKEAHA.112.679084. Epub 2012 Dec 11.

30.

High-dose statins should be used in all acute ischemic strokes.

Moonis M.

Stroke. 2012 Jul;43(7):1992-3. doi: 10.1161/STROKEAHA.111.633354. Epub 2012 May 8. Review. No abstract available.

PMID:
22569933
31.

Leukoaraiosis predicts poor 90-day outcome after acute large cerebral artery occlusion.

Henninger N, Lin E, Baker SP, Wakhloo AK, Takhtani D, Moonis M.

Cerebrovasc Dis. 2012;33(6):525-31. doi: 10.1159/000337335. Epub 2012 Apr 25.

32.

Neuroprotective effects of statins: evidence from preclinical and clinical studies.

Fisher M, Moonis M.

Curr Treat Options Cardiovasc Med. 2012 Jun;14(3):252-9. doi: 10.1007/s11936-012-0174-9.

PMID:
22362392
33.

Selective cognitive patterns resulting from bilateral hippocampal ischemia.

Cachia D, Swearer J, Ferguson W, Moonis M.

Arch Med Sci. 2011 Feb;7(1):168-72. doi: 10.5114/aoms.2011.20626. Epub 2011 Mar 8.

34.

Paroxysmal atrial fibrillation in cryptogenic stroke.

Dangayach NS, Kane K, Moonis M.

Ther Clin Risk Manag. 2011 Jan 28;7:33-7. doi: 10.2147/TCRM.S15079.

35.

Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4.

Pollen DA, Baker S, Hinerfeld D, Swearer J, Evans BA, Evans JE, Caselli R, Rogaeva E, St George-Hyslop P, Moonis M.

Alzheimers Res Ther. 2010 Oct 29;2(5):31. doi: 10.1186/alzrt55. No abstract available.

36.

Antiplatelet agents and proton pump inhibitors - personalizing treatment.

Lin E, Padmanabhan R, Moonis M.

Pharmgenomics Pers Med. 2010;3:101-9. Epub 2010 Jun 28.

37.

Transient hemiglossal denervation during acute internal capsule infarct in the setting of dysarthria-clumsy hand syndrome.

Titelbaum DS, Sodha NB, Moonis M.

AJNR Am J Neuroradiol. 2010 Aug;31(7):1266-7. doi: 10.3174/ajnr.A1874. Epub 2009 Dec 10.

38.

Use of telemedicine to increase thrombolysis and advance care in acute ischemic stroke.

Henninger N, Chowdhury N, Fisher M, Moonis M.

Cerebrovasc Dis. 2009;27 Suppl 4:9-14. doi: 10.1159/000213053. Epub 2009 Jun 18. Review.

PMID:
19546536
39.

Long-term statin therapy and CSF cholesterol levels: implications for Alzheimer's disease.

Evans BA, Evans JE, Baker SP, Kane K, Swearer J, Hinerfeld D, Caselli R, Rogaeva E, St George-Hyslop P, Moonis M, Pollen DA.

Dement Geriatr Cogn Disord. 2009;27(6):519-24. doi: 10.1159/000221835. Epub 2009 May 29.

40.

Intraarterial thrombolysis within the first three hours after acute ischemic stroke in selected patients.

Moonis M.

Stroke. 2009 Jul;40(7):2611-2. doi: 10.1161/STROKEAHA.109.549568. Epub 2009 May 14. No abstract available.

PMID:
19443796
41.

Neurological complications of coronary angiographic procedures.

Duffis EJ, Jones D, Tighe D, Moonis M.

Expert Rev Cardiovasc Ther. 2007 Nov;5(6):1113-21. Review.

PMID:
18035927
42.

Statins differentially affect amyloid precursor protein metabolism in presymptomatic PS1 and non-PS1 subjects.

Hinerfeld DA, Moonis M, Swearer JM, Baker SP, Caselli RJ, Rogaeva E, St George-Hyslop P, Pollen DA.

Arch Neurol. 2007 Nov;64(11):1672-3. No abstract available.

PMID:
17998454
43.

Clinical implications of aspirin resistance.

Patel D, Moonis M.

Expert Rev Cardiovasc Ther. 2007 Sep;5(5):969-75. Review.

PMID:
17867925
44.

Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.

Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, Bi W, Hoge JA, Cohen AD, Ikonomovic MD, Saxton JA, Snitz BE, Pollen DA, Moonis M, Lippa CF, Swearer JM, Johnson KA, Rentz DM, Fischman AJ, Aizenstein HJ, DeKosky ST.

J Neurosci. 2007 Jun 6;27(23):6174-84.

45.

Mining statistically significant associations for exploratory analysis of human sleep data.

Laxminarayan P, Alvarez SA, Ruiz C, Moonis M.

IEEE Trans Inf Technol Biomed. 2006 Jul;10(3):440-50.

PMID:
16871710
46.

Role of heparin and low-molecular-weight heparins in the management of acute ischemic stroke.

Padma V, Fisher M, Moonis M.

Expert Rev Cardiovasc Ther. 2006 May;4(3):405-15. Review.

PMID:
16716101
47.

Familial Alzheimer disease: decreases in CSF Abeta42 levels precede cognitive decline.

Moonis M, Swearer JM, Dayaw MP, St George-Hyslop P, Rogaeva E, Kawarai T, Pollen DA.

Neurology. 2005 Jul 26;65(2):323-5.

PMID:
16043812
48.

HMG-CoA reductase inhibitors improve acute ischemic stroke outcome.

Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M.

Stroke. 2005 Jun;36(6):1298-300. Epub 2005 May 5.

PMID:
15879346
49.

HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke.

Moonis M, Fisher M.

Expert Rev Neurother. 2004 Mar;4(2):241-7. Review.

PMID:
15853565
50.

Thrombolytic therapy for acute ischemic stroke: 3 h and beyond.

Padma V, Fisher M, Moonis M.

Expert Rev Neurother. 2005 Mar;5(2):223-33. Review.

PMID:
15853492

Supplemental Content

Loading ...
Support Center